Ignite Creation Date:
2024-05-05 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00722735
Status:
COMPLETED
Last Update Posted:
2009-06-11
First Post:
2008-07-25
Brief Title:
Finafloxacin 300 mg Twice a Day bid Versus Ciprofloxacin 250 mg Twice a Day bid in Patients With Lower Uncomplicated UTI uUTI
Sponsor:
MerLion Pharmaceuticals GmbH
Organization:
MerLion Pharmaceuticals GmbH
Organization Data
Organization:
MerLion Pharmaceuticals GmbH
Class:
INDUSTRY
Study ID:
FINA-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MerLion Pharmaceuticals GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jasper Hein MD Prinzipal Investigator
Old Organization:
Practicing Physician